Sialidosis is a rare genetic disorder characterized by the deficiency of an enzyme called neuraminidase. It is classified under ICD10 code E77.1. The corresponding ICD9 code for Sialidosis is 277.7. Sialidosis affects multiple organs and can lead to various symptoms including skeletal abnormalities, intellectual disability, and impaired vision. Early diagnosis and management are crucial for improving the quality of life for individuals with Sialidosis.
Sialidosis is a rare genetic disorder that affects the metabolism of sialic acid, resulting in a variety of symptoms. In the International Classification of Diseases, 10th Revision (ICD-10), Sialidosis is classified under E77.1. This code falls under the category of "Lipidoses and other disorders of metabolism," specifically referring to the deficiency of enzymes involved in the breakdown of complex molecules.
On the other hand, in the previous edition, the International Classification of Diseases, 9th Revision (ICD-9), Sialidosis was classified under 277.85. This code was under the category of "Other specified disorders of metabolism," which encompassed various metabolic disorders not specifically mentioned in other categories.
Both ICD-9 and ICD-10 codes provide a standardized way of classifying and documenting diseases and conditions. These codes are used by healthcare professionals for billing purposes, statistical analysis, and to ensure accurate communication between healthcare providers.
It is important to note that while ICD codes provide a useful framework for categorizing diseases, they do not provide detailed information about the specific characteristics or severity of a condition. Therefore, it is essential to consult with healthcare professionals and medical resources for a comprehensive understanding of Sialidosis and its management.